April, 2019 – Chemopharm Sdn Bhd, an Everlife investment and leading laboratory and medical
devices distributor headquartered in Malaysia, is pleased to announce the completion of an asset
purchase for Mindray hematology and clinical chemistry analyzers from Histocenter (M) Sdn Bhd in
Chemopharm has an existing agreement with Mindray to distribute the leading Chinese
IVD company’s CLIA immunoassay and 5-part Hematology products, and with the completion of
this transaction, Chemopharm will represent Mindray in Malaysia across their 3 biggest IVD
The hematology, clinical chemistry and CLIA segments are traditionally the largest segments within
the IVD space and are expected to grow at around 8% p.a. in the next 3 years.
This is largely driven by the expansion of medical facilities in 2 nd tier cities and middle-class hospitals across Malaysia, both in the public and private sectors. Mindray’s analyzers uniquely meet the needs of this high-
growth segment by providing products with high quality specifications at highly competitive prices.
This deal and the expanded partnership with Mindray will allow Chemopharm to boost its presence
within the IVD space in Malaysia. Ms Mok Hueh Min, Group CEO, Chemopharm Group stated:
“This deal represents a significant turning point in our partnership with Mindray.
The expanded portfolio allows us to improve our offering and value proposition to our customers and to
accelerate the growth of the business in Malaysia. We look forward to strengthening the
partnership and to work together to provide customers with continued top quality service and
Chemopharm is a leading regional provider of products, solutions and services for the laboratory,
analytical testing, life science and healthcare industries. It is headquartered in Malaysia and has
operations in Singapore, Thailand, Indonesia, Vietnam and the Philippines.
For more information, please visit Chemopharm here.
Founded in 1991, Mindray is one of the leading global providers of medical devices and solutions
Firmly committed to their mission of “advance medical technologies to make healthcare more
accessible”, Mindray is dedicated to innovation in the fields of Patient Monitoring & Life Support, In-
Vitro Diagnostics, and Medical Imaging System.
Today, Mindray’s products and services can be found in healthcare facilities in over 190 countries and regions. In China, Mindray’s products and solutions can be found in nearly 110,000 medical institutions and 99% of Class A tertiary hospitals.